Newly in diagnosis of type 1 diabetes mellitus

سال انتشار: 1398
نوع سند: مقاله کنفرانسی
زبان: انگلیسی
مشاهده: 442

نسخه کامل این مقاله ارائه نشده است و در دسترس نمی باشد

این مقاله در بخشهای موضوعی زیر دسته بندی شده است:

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این مقاله:

شناسه ملی سند علمی:

GDRC12_001

تاریخ نمایه سازی: 5 بهمن 1398

چکیده مقاله:

Introduction: Newly in diagnosis of type 1 diabetes mellitus As defined by the ADA, the diagnosis of diabetes is made when: fasting plasma glucose is 126 mg/dl ≤, 2-hour plasma glucose in oral glucose tolerance test 200 mg/dl ≤ , random glucose is 200 mg/dl ≤ in presence of classic symptoms of hyperglycemia, or HbA1c is 6.5% ≤. In pediatrics, HbA1c remains controversial. Differential diagnoses of diabetes are diagnostic challenges. For example, in transient benign hyperglycemia due to stress, plasma glucose may occasionally reach levels of 250-350 mg/dl. In this condition, insulin or c-peptide level will be elevated, but in new onset of type 1 diabetes will be inappropriately normal or mildly low. Also, measurement of diabetes auto antibodies with or without assessment of beta cell integrity by measuring FPIR can be decisive.Materials & Methods: Newly in diagnosis of type 1 diabetes mellitus As defined by the ADA, the diagnosis of diabetes is made when: fasting plasma glucose is 126 mg/dl ≤, 2-hour plasma glucose in oral glucose tolerance test 200 mg/dl ≤ , random glucose is 200 mg/dl ≤ in presence of classic symptoms of hyperglycemia, or HbA1c is 6.5% ≤. In pediatrics, HbA1c remains controversial. Differential diagnoses of diabetes are diagnostic challenges. For example, in transient benign hyperglycemia due to stress, plasma glucose may occasionally reach levels of 250-350 mg/dl. In this condition, insulin or c-peptide level will be elevated, but in new onset of type 1 diabetes will be inappropriately normal or mildly low. Also, measurement of diabetes auto antibodies with or without assessment of beta cell integrity by measuring FPIR can be decisive.Results: Newly in diagnosis of type 1 diabetes mellitus As defined by the ADA, the diagnosis of diabetes is made when: fasting plasma glucose is 126 mg/dl ≤, 2-hour plasma glucose in oral glucose tolerance test 200 mg/dl ≤ , random glucose is 200 mg/dl ≤ in presence of classic symptoms of hyperglycemia, or HbA1c is 6.5% ≤. In pediatrics, HbA1c remains controversial. Differential diagnoses of diabetes are diagnostic challenges. For example, in transient benign hyperglycemia due to stress, plasma glucose may occasionally reach levels of 250-350 mg/dl. In this condition, insulin or c-peptide level will be elevated, but in new onset of type 1 diabetes will be inappropriately normal or mildly low. Also, measurement of diabetes auto antibodies with or without assessment of beta cell integrity by measuring FPIR can be decisive.Conclusion & discussion: Newly in diagnosis of type 1 diabetes mellitus As defined by the ADA, the diagnosis of diabetes is made when: fasting plasma glucose is 126 mg/dl ≤, 2-hour plasma glucose in oral glucose tolerance test 200 mg/dl ≤ , random glucose is 200 mg/dl ≤ in presence of classic symptoms of hyperglycemia, or HbA1c is 6.5% ≤. In pediatrics, HbA1c remains controversial. Differential diagnoses of diabetes are diagnostic challenges. For example, in transient benign hyperglycemia due to stress, plasma glucose may occasionally reach levels of 250-350 mg/dl. In this condition, insulin or c-peptide level will be elevated, but in new onset of type 1 diabetes will be inappropriately normal or mildly low. Also, measurement of diabetes auto antibodies with or without assessment of beta cell integrity by measuring FPIR can be decisive.

کلیدواژه ها:

نویسندگان

Hosein Shabani Mirzaee

Assistant Professor of Pediatric Endocrinology, Pediatric Endocrinology Department, Bahrami Children s Hospital, Tehran University of Medical Sciences, Tehran, Iran